Gezginci-Oktayoglu, S. Et Al. 2018. 4-Methylcatechol prevents streptozotocin-induced acute kidney injury through modulating NGF/TrkA and ROS-related Akt/GSK3 beta/beta-catenin pathways. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.64 , 52-59.

Gezginci-Oktayoglu, S., Coskun, E., Ercin, M., & Bolkent, S., (2018). 4-Methylcatechol prevents streptozotocin-induced acute kidney injury through modulating NGF/TrkA and ROS-related Akt/GSK3 beta/beta-catenin pathways. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.64, 52-59.

Gezginci-Oktayoglu, Selda Et Al. "4-Methylcatechol prevents streptozotocin-induced acute kidney injury through modulating NGF/TrkA and ROS-related Akt/GSK3 beta/beta-catenin pathways," INTERNATIONAL IMMUNOPHARMACOLOGY , vol.64, 52-59, 2018

Gezginci-Oktayoglu, Selda Et Al. "4-Methylcatechol prevents streptozotocin-induced acute kidney injury through modulating NGF/TrkA and ROS-related Akt/GSK3 beta/beta-catenin pathways." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.64, pp.52-59, 2018

Gezginci-Oktayoglu, S. Et Al. (2018) . "4-Methylcatechol prevents streptozotocin-induced acute kidney injury through modulating NGF/TrkA and ROS-related Akt/GSK3 beta/beta-catenin pathways." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.64, pp.52-59.

@article{article, author={Selda OKTAYOĞLU Et Al. }, title={4-Methylcatechol prevents streptozotocin-induced acute kidney injury through modulating NGF/TrkA and ROS-related Akt/GSK3 beta/beta-catenin pathways}, journal={INTERNATIONAL IMMUNOPHARMACOLOGY}, year=2018, pages={52-59} }